In this webinar, Prof. Marjoleinde Bruin-Weller and Dr. Pascal H.P. de Jong will discuss the impact Atopic Dermatitis has on patients while also focusing on the treatment algorithm and the role of JAK inhibitors can with AD patients.
After participating in this webinar attendance should have a clear understanding of the holistic impact atopic dermatitis has on patients, how this could be addressed in clinical practice and how JAK Inhibitors can be included in the AD treatment algorithm, including clinical learnings from the field of Rheumatology.
Rheumatologist, ErasmusMC, Rotterdam
Postdoctoral researcher, ErasmusMC, Rotterdam
Rheumatologist, Maasstad hospital, Rotterdam
Rheumatology trainee in ErasmusMC and Maasstad hospital, Rotterdam
PhD-student department of rheumatology, ErasmusMC, Rotterdam